Home › Lung Diseases › Tennessee › Memphis
Lung Diseases clinical trials in Memphis, TN
3 studies for Lung Diseases are looking for participants at sites in and around Memphis (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
RecruitingPhase 3
- Baptist Memorial Hospital-Memphis, Memphis
Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
RecruitingPhase 2
- Baptist Cancer Center, Memphis
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
RecruitingPhase 1/2
- Baptist Memorial Hospital Baptist Cancer Center, Memphis
About Lung Diseases
Lung diseases are disorders or infections that affect the lungs and cause breathing problems. Some can lead to respiratory failure. Find out more about prevention, living with lung diseases, and treatment.
More about Lung Diseases on MedlinePlus
Lung Diseases trials in other cities
- Houston, TX16 studies
- Boston, MA14 studies
- Durham, NC13 studies
- New York City, NY13 studies
- Pittsburgh, PA11 studies
- Dallas, TX10 studies
- Los Angeles, CA10 studies
- Ann Arbor, MI10 studies
- Miami, FL10 studies
- Columbus, OH10 studies
- Chicago, IL9 studies
- Washington, DC9 studies
Other studies in Memphis
- Cancer (all types)30 studies
- Non-Small Cell Lung Cancer25 studies
- Breast Cancer21 studies
- Sickle Cell Disease19 studies
- Acute Lymphoblastic Leukemia17 studies
- Lung Cancer17 studies
- Acute Myeloid Leukemia14 studies
- Heart Failure12 studies
- Melanoma11 studies
- Soft Tissue Sarcoma10 studies
- Colorectal Cancer10 studies
- Type 2 Diabetes10 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.